Vergoeding 2017-2021 voor ATC-subgroep G04CA : Alfa-blokkers
- Raming voor de totale Zvw-populatie
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| G04CA01 Alfuzosine (Xatral ®) | 925.560 | 899.210 | 911.830 | 847.420 | 786.510 |
| G04CA02 Tamsulosine (Omnic ®) | 1.982.600 | 2.013.400 | 2.016.800 | 2.070.600 | 1.914.700 |
| G04CA03 Terazosine (Hytrin ®) | 63.051 | 57.132 | 57.170 | 55.417 | 17.352 |
| G04CA04 Silodosine (Silodyx ®) | 791.800 | 875.920 | 934.020 | 910.740 | 856.050 |
| G04CA52 Tamsulosine met dutasteride (Combodart ®) | 8.698.400 | 9.043.500 | 9.084.200 | 7.292.700 | 3.225.200 |
| G04CA53 Tamsulosine met solifenacine (Vesomni ®) | 2.649.100 | 2.961.600 | 3.333.100 | 3.543.400 | 3.862.700 |
| Totaal | 15.110.511 | 15.850.762 | 16.337.120 | 14.720.277 | 10.662.512 |